OTC Drug And Dietary Supplement Global Market Opportunities And Strategies To 2033

Description

The OTC (over the counter) drug and dietary supplement market encompasses products that consumers can purchase without a prescription for self-care and health maintenance.

The OTC drugs and dietary supplement market consists of sales, by entities (organizations, sole traders and partnerships), of OTC drugs and dietary supplement. OTC drugs are used to treat various minor health issues, while dietary supplements provide nutritional support, such as vitamins, minerals, and other substances. These products are widely utilized by individuals seeking to manage minor ailments or boost their overall health without the need for medical consultation. They play a critical role in public health by offering accessible and often more affordable options for symptom relief and wellness.

The global OTC drug and dietary supplement market was valued at $223,312.9 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 6.0%.

Rise In Pharma Research And Development (R&D) Expenditure

During the historic period, the rise in pharma research and development (R&D) expenditure drove the growth of the OTC drug and dietary supplement market. Increased investment in research and development (R&D) resulted in the creation of advanced OTC drugs and dietary supplements. These innovations encompassed superior formulations, enhanced delivery methods and improved safety standards, enhancing product appeal among consumers. For instance, according to a report published by the European Federation of Pharmaceutical Industries and Associations, a Belgium-based pharmaceuticals-based trade association, in 2021 European health industries invested about 41.5 billion euros ($44.47 billion) for research and development (R&D) expenditure, an increase compared to 39.65 billion euros ($42.49 billion) in 2020. Therefore, a rise in pharma research and development (R&D) expenditure supported the growth of the OTC drug and dietary supplement market.

New Over-The-Counter Option For Opioid Overdose Reversal

Companies operating in the OTC drug and dietary supplement market are deploying new over-the-counter options for opioid overdose reversal. It facilitates access to a critical life-saving intervention, potentially lowering fatalities in emergency scenarios where immediate medical help may be limited or unavailable. For instance, in April 2024, Amneal Pharmaceuticals, Inc., a US-based generics and specialty pharmaceutical company, has announced the U.S. FDA approval and availability of its over-the-counter (OTC) Naloxone Hydrochloride (Naloxone HCI) Nasal Spray, USP, 4mg. This product is a generic equivalent to OTC NARCAN(R) HCI Nasal Spray and is intended for the emergency treatment of opioid overdoses, including those involving heroin, fentanyl and prescription opioids. Amneal's Naloxone HCI Nasal Spray is formulated to quickly reverse the life-threatening effects of an opioid overdose by binding to opioid receptors and restoring normal respiration within two to three minutes in individuals whose breathing has significantly slowed or stopped.

The global OTC drug and dietary supplement market is fragmented, with a few large number of players operating in the market. The top ten competitors in the market made up 21.5% of the total market in 2023.

OTC Drug And Dietary Supplement Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global OTC drug and dietary supplement market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for OTC drug and dietary supplement? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The OTC drug and dietary supplement market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider OTC drug and dietary supplement market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by category, by dosage form and by distribution channel.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the OTC drug and dietary supplement market.
Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by category, by dosage form and by distribution channel in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for OTC drugs and dietary supplement providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Category: Vitamin And Dietary Supplements; Cough And Cold Dosage Forms; Analgesics; Gastrointestinal Dosage Forms; Skin; Other Categories
2) By Dosage Form: Tablets; Hard Capsules; Powders; Ointments; Soft Capsules; Liquids; Other Dosage Forms
3) By Distribution Channel: Pharmacies; Grocery Stores; Vitamin And Health Food Stores; Online Pharmacies
Companies Mentioned: Nestle S.A.; Procter & Gamble Co.; Haleon plc; Abbott Laboratories; Sanofi S.A.
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; OTC drug and dietary supplement indicators comparison.
Data segmentations: Country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: o&s1314

1 Executive Summary

1.1 OTC Drug And Dietary Supplement - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 OTC Drug And Dietary Supplement Market Definition And Segmentations
6.4 Market Segmentation By Category
- 6.4.1 Vitamin And Dietary Supplements
- 6.4.2 Cough And Cold Products
- 6.4.3 Analgesics
- 6.4.4 Gastrointestinal Products
- 6.4.5 Skin
- 6.4.6 Other Categories
6.5 Market Segmentation By Dosage Form
- 6.5.1 Tablets
- 6.5.2 Hard Capsules
- 6.5.3 Powders
- 6.5.4 Ointments
- 6.5.5 Soft Capsules
- 6.5.6 Liquids
- 6.5.7 Other Dosage Forms
6.6 Market Segmentation By Distribution Channel
- 6.6.1 Pharmacies
- 6.6.2 Grocery Stores
- 6.6.3 Vitamin And Health Food Stores
- 6.6.4 Online Pharmacies

7 Major Market Trends

7.1 Expansion Of Production Capabilities In Dietary Supplements And OTC Drugs
7.2 New Over-The-Counter Option For Opioid Overdose Reversal
7.3 Launch Of Natural Herb-Based Supplement For Nursing Mothers
7.4 Introduction Of OTC Drug Line For Pain And Allergy Relief
7.5 Innovation In Women's Health Pharmaceuticals

8 OTC Drug And Dietary Supplement Market - Macro-Economic Scenario

8.1 COVID-19 Impact On The OTC Drug And Dietary Supplement Market
8.2 Impact Of The War In Ukraine On The OTC Drug And Dietary Supplement Market
8.3 Impact Of High Inflation On The OTC Drug And Dietary Supplement Market

9 Global Market Size And Growth

9.1 Market Size
9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
- 9.2.1 Market Drivers 2018 - 2023
- 9.2.2 Market Restraints 2018 - 2023
9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
- 9.3.1 Market Drivers 2023 - 2028
- 9.3.2 Market Restraints 2023 - 2028

10 Global OTC Drug And Dietary Supplement Market Segmentation

10.1 Global OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.2 Global OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.3 Global OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 OTC Drug And Dietary Supplement Market, Regional and Country Analysis

11.1 Global OTC Drug And Dietary Supplement Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.2 Global OTC Drug And Dietary Supplement Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

12.1 Summary
- 12.1.1 Market Overview
- 12.1.2 Region Information
- 12.1.3 Market Information
- 12.1.4 Background Information
- 12.1.5 Government Initiatives
- 12.1.6 Regulations
- 12.1.7 Regulatory Bodies
- 12.1.8 Major Associations
- 12.1.9 Taxes Levied
- 12.1.10 Corporate Tax Structure
- 12.1.11 Investments
- 12.1.12 Major Companies
12.2 Asia-Pacific OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.3 Asia-Pacific OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.4 Asia-Pacific OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific OTC Drug And Dietary Supplement Market: Country Analysis
12.6 China Market
12.7 Summary
- 12.7.1 Market Overview
- 12.7.2 Country Information
- 12.7.3 Market Information
- 12.7.4 Background Information
- 12.7.5 Government Initiatives
- 12.7.6 Regulations
- 12.7.7 Regulatory Bodies
- 12.7.8 Major Associations
- 12.7.9 Taxes Levied
- 12.7.10 Corporate Tax Structure
- 12.7.11 Investments
- 12.7.12 Major Companies
12.8 China OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.9 China OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.10 China OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.11 India Market
12.12 India OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.13 India OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.14 India OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.15 Japan Market
12.16 Japan OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.17 Japan OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.18 Japan OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.19 Australia Market
12.20 Australia OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.21 Australia OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.22 Australia OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.23 Indonesia Market
12.24 Indonesia OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.25 Indonesia OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.26 Indonesia OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.27 South Korea Market
12.28 South Korea OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.29 South Korea OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.30 South Korea OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

13.1 Summary
- 13.1.1 Market Overview
- 13.1.2 Region Information
- 13.1.3 Market Information
- 13.1.4 Background Information
- 13.1.5 Government Initiatives
- 13.1.6 Regulations
- 13.1.7 Regulatory Bodies
- 13.1.8 Major Associations
- 13.1.9 Taxes Levied
- 13.1.10 Corporate tax structure
- 13.1.11 Investments
- 13.1.12 Major Companies
13.2 Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.3 Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.5 Western Europe OTC Drug And Dietary Supplement Market: Country Analysis
13.6 UK Market
13.7 UK OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.8 UK OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.9 UK OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.10 Germany Market
13.11 Germany OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.12 Germany OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.13 Germany OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.14 France Market
13.15 France OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.16 France OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.17 France OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.18 Italy Market
13.19 Italy OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.20 Italy OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.21 Italy OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.22 Spain Market
13.23 Spain OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.24 Spain OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.25 Spain OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

14.1 Summary
- 14.1.1 Market Overview
- 14.1.2 Region Information
- 14.1.3 Market Information
- 14.1.4 Background Information
- 14.1.5 Government Initiatives
- 14.1.6 Regulations
- 14.1.7 Regulatory Bodies
- 14.1.8 Major Associations
- 14.1.9 Taxes Levied
- 14.1.10 Corporate Tax Structure
- 14.1.11 Investments
- 14.1.12 Major Companies
14.2 Eastern Europe OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.3 Eastern Europe OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe OTC drug And Dietary Supplement Market: Country Analysis
14.6 Russia Market
14.7 Russia OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.8 Russia OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.9 Russia OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

15.1 Summary
- 15.1.1 Market Overview
- 15.1.2 Region Information
- 15.1.3 Market Information
- 15.1.4 Background Information
- 15.1.5 Government Initiatives
- 15.1.6 Regulations
- 15.1.7 Regulatory Bodies
- 15.1.8 Major Associations
- 15.1.9 Taxes Levied
- 15.1.10 Corporate Tax Structure
- 15.1.11 Investments
- 15.1.12 Major Companies
15.2 North America OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.3 North America OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.4 North America OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.5 North America OTC Drug And Dietary Supplement Market: Country Analysis
15.6 USA Market
15.7 Summary
- 15.7.1 Market Overview
- 15.7.2 Country Information
- 15.7.3 Market Information
- 15.7.4 Background Information
- 15.7.5 Government Initiatives
- 15.7.6 Regulations
- 15.7.7 Regulatory Bodies
- 15.7.8 Major Associations
- 15.7.9 Taxes Levied
- 15.7.10 Corporate Tax Structure
- 15.7.11 Investments
- 15.7.12 Major Companies
15.8 USA OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.9 USA OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.10 USA OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.11 Canada Market
15.12 Canada OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.13 Canada OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.14 Canada OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

16.1 Summary
- 16.1.1 Market Overview
- 16.1.2 Region Information
- 16.1.3 Market Information
- 16.1.4 Background Information
- 16.1.5 Government Initiatives
- 16.1.6 Regulations
- 16.1.7 Regulatory Bodies
- 16.1.8 Major Associations
- 16.1.9 Taxes Levied
- 16.1.10 Corporate Tax Structure
- 16.1.11 Investments
- 16.1.12 Major Companies
16.2 South America OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.3 South America OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.4 South America OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.5 South America OTC Drug And Dietary Supplement Market: Country Analysis
16.6 Brazil Market
16.7 Brazil OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.8 Brazil OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

17.1 Summary
- 17.1.1 Market Overview
- 17.1.2 Region Information
- 17.1.3 Market Information
- 17.1.4 Background Information
- 17.1.5 Government Initiatives
- 17.1.6 Regulations
- 17.1.7 Regulatory Bodies
- 17.1.8 Major Associations
- 17.1.9 Taxes Levied
- 17.1.10 Corporate Tax Structure
- 17.1.11 Investments
- 17.1.12 Major Companies
17.2 Middle East OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.3 Middle East OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

18.1 Summary
- 18.1.1 Market Overview
- 18.1.2 Region Information
- 18.1.3 Market Information
- 18.1.4 Background Information
- 18.1.5 Government Initiatives
- 18.1.6 Regulations
- 18.1.7 Regulatory Bodies
- 18.1.8 Major Associations
- 18.1.9 Taxes Levied
- 18.1.10 Corporate Tax Structure
- 18.1.11 Investments
- 18.1.12 Major Companies
18.2 Africa OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.3 Africa OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.4 Africa OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

19.1 Company Profiles
19.2 Nestle S.A.
- 19.2.1 Company Overview
- 19.2.2 Products And Services
- 19.2.3 Business Strategy
- 19.2.4 Financial Overview
19.3 The Procter & Gamble Company
- 19.3.1 Company Overview
- 19.3.2 Products And Services
- 19.3.3 Financial Overview
19.4 Haleon plc
- 19.4.1 Company Overview
- 19.4.2 Products And Services
- 19.4.3 Business Strategy
- 19.4.4 Financial Overview
19.5 Abbott Laboratories
- 19.5.1 Company Overview
- 19.5.2 Products And Services
- 19.5.3 Business Strategy
- 19.5.4 Financial Overview
19.6 Sanofi S.A
- 19.6.1 Company Overview
- 19.6.2 Products And Services
- 19.6.3 Business Strategy
- 19.6.4 Financial Overview

20 Other Major And Innovative Companies

20.1 Reckitt Benckiser Group plc
- 20.1.1 Company Overview
- 20.1.2 Products And Services
20.2 Bayer AG
- 20.2.1 Company Overview
- 20.2.2 Products And Services
20.3 Church & Dwight Co. Inc
- 20.3.1 Company Overview
- 20.3.2 Products And Services
20.4 Nature's Bounty Co
- 20.4.1 Company Overview
- 20.4.2 Products And Services
20.5 Perrigo Company plc
- 20.5.1 Company Overview
- 20.5.2 Products And Services
20.6 GNC Holdings Inc.
- 20.6.1 Company Overview
- 20.6.2 Products And Services
20.7 Sun Pharmaceutical Industries Ltd
- 20.7.1 Company Overview
- 20.7.2 Products And Services
20.8 Novartis AG
- 20.8.1 Company Overview
- 20.8.2 Products And Services
20.9 Pfizer Inc
- 20.9.1 Company Overview
- 20.9.2 Products And Services
20.10 Merck & Co. Inc
- 20.10.1 Company Overview
- 20.10.2 Products And Services
20.11 Pharmavite LLC
- 20.11.1 Company Overview
- 20.11.2 Products And Services
20.12 Hain Celestial Group Inc
- 20.12.1 Company Overview
- 20.12.2 Products And Services
20.13 Blackmores Limited
- 20.13.1 Company Overview
- 20.13.2 Products And Services
20.14 Cipla Inc
- 20.14.1 Company Overview
- 20.14.2 Products And Services
20.15 Amway
- 20.15.1 Company Overview
- 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

23.1 Dr. Reddy's Laboratories Acquired MenoLabs
23.2 Dexcel Pharma Acquired Teva Pharmaceutical Industries Ltd
23.3 Cipla Limited Acquired Actor Pharma
23.4 SGS S.A. Acquired Nutrasource Pharmaceutical and Nutraceutical Services Inc.
23.5 The Kirin Holdings Company Limited Acquired Blackmores Limited
23.6 Balchem Corporation Acquired Bergstrom Nutrition
23.7 Glenmark Pharmaceuticals Ltd Acquired Wockhardt Ltd
23.8 Acino Acquired Aspen Pharmacare Holdings Limited
23.9 Douglas Acquired Disapo
23.10 Merieux NutriSciences Acquired Dyad Labs
23.11 Laboratorios Rubio Acquired Fisiopharma S.r.l.
23.12 Fidia Farmaceutici Acquired Sanofi

24 Opportunities And Strategies

24.1 Global OTC Drug And Dietary Supplement Market In 2028 - Countries Offering Most New Opportunities
24.2 Global OTC Drug And Dietary Supplement Market In 2028 - Segments Offering Most New Opportunities
24.3 Global OTC Drug And Dietary Supplement Market In 2028 - Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies

25 OTC Drug And Dietary Supplement Market, Conclusions And Recommendations

25.1 Conclusions
25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People

26 Appendix

26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer